The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, ...

A 2022 study estimates that at-home flu tests have a sensitivity of about 63% if the test is performed within 72 hours of ...

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

CoDiagnostics secures its first patent for the Co-Dx PCR platform in Australia, strengthening IP protection as the point-of-care system awaits regulatory clearance.

WHO has prequalified two Covid-19 rapid antigen tests for the first time, confirming long-term quality and enabling UN ...

WHO has prequalified two rapid COVID-19 antigen tests, confirming their safety and quality and expanding access to fast, ...

A 29-year-old woman was referred to Tufts Medical Center for undifferentiated bilateral anterior and intermediate uveitis.The ...

Flu, viral fever, and COVID-19 all cause fever and respiratory symptoms, but key differences in onset, symptom patterns, ...

The Asian longhorn tick is native to Japan, China, Korea, and parts of Russia. Australia and New Zealand imported the tick a ...

For the first time, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting COVID-19, the ...

This is shaping up to be yet another severe flu season, fueled by a new influenza variant. Here's how to use home flu tests ...